Search results for: 'pla3 growth chambers'

The global clinical diagnostics market is poised for strong growth, driven by increased adoption of advanced diagnostics technologies, greater investment in laboratories, and improved access to molecular and immunodiagnostic testing facilities. In 2025, the industry continued its transformation, establishing testing systems as intelligent systems...

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

This study highlights emerging companies in the respiratory care industry. Most respiratory care companies focus on device connectivity and developing smart devices that can assist in better management of chronic respiratory diseases and reduce healthcare costs. The COVID-19 pandemic increased the focus on the benefits of remote care. Respiratory s...

Conversational AI solutions are designed to enhance communication and coordination among healthcare stakeholders. These voice and text applications automate human information gathering and communications and represent a growing opportunity for healthcare organizations to improve clinician efficiency, operational and administrative efficiency, healt...

The mHealth enabled care market is growing at a rapid pace with over 0.15 million health apps in 2015 leading to an endless number of possibilities of smartphone usage for revolutionizing healthcare. From reading and analyzing a patient’s vital body data, medication adherence, and chronic disease management to early diagnosis of complex disorders w...

As global clinical pipelines witness a surge in complex novel therapies, there is a general inclination toward improving trial design through adaptive trial designs with technology-enabled solutions for planning and execution. Artificial intelligence (AI) is gaining large-scale recognition in terms of supporting decentralized trial designs and allo...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...

This analysis provides an overview and advancements in the oral solid dosage formulation industry, including an evaluation of the current industry scenario, competitive landscape, and regulatory landscape. The scope of the analysis is global, focusing on North America (NA), Europe, Asia-Pacific (APAC), the Middle East, and Latin America (LATAM). It...

With increased interest in precision medicine and demand for telemedicine and digital solutions in hospitals and laboratories, digital pathology has the opportunity to grow in its clinical, pharma, and research applications. Advances in AI-based algorithms and data management and analysis software offer immense potential in improving workflow, aut...